COMPLEMENT ACTIVATION INVIVO IN CANCER-PATIENTS RECEIVING C-PARVUM IMMUNOTHERAPY

被引：9
|
作者：
BIRAN, H
MOAKE, JL
REED, RC
GUTTERMAN, JU
HERSH, EM
FREIREICH, EJ
MAVLIGIT, GM
机构：
[1] UNIV TEXAS,SCH MED,DIV HEMATOL,HOUSTON,TX 77025
[2] UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT DEV THERAPEUTICS,HOUSTON,TX 77025
来源：
BRITISH JOURNAL OF CANCER | 1976年 / 34卷 / 05期
关键词：
D O I：
10.1038/bjc.1976.203
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：493 / 499
页数：7
相关论文
共 50 条
  • [21] INVIVO ACTIVATION-ANALYSIS FOLLOWING NEUTRON THERAPY IN CANCER-PATIENTS
    BOND, CD
    THEUS, RB
    AUGUST, LS
    SHAPIRO, P
    ROGERS, CC
    COSTA, G
    TRANSACTIONS OF THE AMERICAN NUCLEAR SOCIETY, 1974, 19 (OCT27): : 52 - 52
  • [22] INVIVO ACTIVATION-ANALYSIS FOLLOWING NEUTRON THERAPY IN CANCER-PATIENTS
    BOND, CD
    THEUS, RB
    AUGUST, LS
    SHAPIRO, P
    BULLETIN OF THE AMERICAN PHYSICAL SOCIETY, 1974, 19 (04): : 551 - 551
  • [23] INHIBITION OF MACROPHAGE ACTIVATION FOLLOWING C-PARVUM BY PHARMACOLOGIC BLOCKADE OF PROLACTIN-RELEASE
    BERNTON, EW
    HARTMANN, DP
    GILBREATH, MJ
    MELTZER, MS
    HOLADAY, IW
    JOURNAL OF LEUKOCYTE BIOLOGY, 1985, 38 (01) : 125 - 125
  • [24] INTERFERON INDUCTION AND ACTIVATION OF NATURAL-KILLER CELLS IN MICE BY INJECTION OF C-PARVUM
    CHMIELARCZYK, W
    STORCH, E
    KIRCHNER, H
    IMMUNOBIOLOGY, 1984, 168 (1-2) : 76 - 76
  • [25] COMPLEMENT ACTIVATION IN CANCER-PATIENTS UNDERGOING IMMUNOTHERAPY WITH INTERLEUKIN-2 (IL-2) - BINDING OF COMPLEMENT AND C-REACTIVE PROTEIN BY IL-2-ACTIVATED LYMPHOCYTES
    VACHINO, G
    GELFAND, JA
    ATKINS, MB
    TAMERIUS, JD
    DEMCHAK, P
    MIER, JW
    BLOOD, 1991, 78 (10) : 2505 - 2513
  • [26] ACTIVE, SPECIFIC IMMUNOTHERAPY WITH AUTOLOGOUS TUMOR-CELLS ADMIXED WITH C-PARVUM IN PATIENTS WITH METASTATIC RENAL-CELL CARCINOMA
    KURTH, KH
    MARQUET, R
    JONAS, U
    WARNAAR, SD
    PROSTATE, 1983, 4 (06): : 660 - 661
  • [27] TOXICITY OF INTRAVENOUS CORYNEBACTERIUM-PARVUM IN CANCER-PATIENTS
    GILL, PG
    MORRIS, PJ
    BRITISH JOURNAL OF SURGERY, 1977, 64 (04) : 31 - 31
  • [28] INVIVO REDUCTION OF TUMOR-CELL DNA CONTENT BY PYRAN, C-PARVUM AND 5-FLUOROURACIL
    CONNOLLY, K
    KAPLAN, AM
    FEDERATION PROCEEDINGS, 1981, 40 (03) : 761 - 761
  • [29] ERYTHROPOIESIS IN CANCER-PATIENTS UNDERGOING IMMUNOTHERAPY
    ASCENSAO, JL
    LIU, SJ
    CARO, J
    PODACK, E
    MITTELMAN, A
    ZANJANI, ED
    ZHAO, YL
    MOLECULAR BIOLOGY OF ERYTHROPOIESIS, 1989, 271 : 197 - 204
  • [30] IMMUNOLOGICAL MONITORING OF CANCER-PATIENTS DURING TREATMENT WITH CORYNEBACTERIUM PARVUM
    DIMITROV, NV
    ISRAEL, L
    PELTIER, A
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 258 - 258
12345